EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations
Future oncology (London, England), 2021-06, Vol.17 (18), p.2395-2408 [Peer Reviewed Journal]ISSN: 1479-6694 ;EISSN: 1744-8301 ;DOI: 10.2217/fon-2021-0195 ;PMID: 33855865
Full text available